Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro

Reproductive Toxicology

Volumn 21, Issue 1, 2006, Pages 83-93

  Longo, Monica ^a   Zanoncelli, Sara ^a   Manera, Debora ^a   Brughera, Marco ^a   Colombo, Paolo ^a   Lansen, Jacqueline ^a   Mazué, Guy ^b   Gomes, Melba ^c   Taylor, Walter R J ^c,d   Olliaro, Piero ^c,e  

^a NERVIANO MEDICAL SCIENCES   (Italy)

^b Aux Fermes de Bosne   (France)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antimalarial drug; Dihydroartemisinin; Embryotoxicity; Malaria; Whole embryo culture; Yolk sac angiogenesis; Yolk sac hematopoiesis

Indexed keywords

DIHYDROARTEMISININ;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRANCHIAL ARCH; CELL DEATH; CONTROLLED STUDY; EMBRYO; EMBRYO CULTURE; EMBRYOTOXICITY; ERYTHROCYTE; FEMALE; HEMATOPOIESIS; IN VITRO STUDY; MALE; NEURAL TUBE DEFECT; NONHUMAN; RAT; SOMITE; TERATOLOGY; YOLK SAC;

ANIMALIA;

EID: 30044436035     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2005.05.005     Document Type: Article

References (36)

1. F. Nosten, S.J. Rogerson, J.G. Beeson, R. McGready, T.K. Mutabingwa, and B. Brabin Malaria in pregnancy and the endemicity spectrum: what can we learn? Trends Parasitol 20 9 2004 425 432
2. A.G. Craig Pregnancy-associated malaria - on the brink? Trends Parasitol 20 5 2004 201 204
3. F.O. Ter Kuile, M.E. Parise, and F.H. Verhoeff The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa Am J Trop Med Hyg 71 Suppl. 2 2004 41 54
4. World Health Organization Regional Office for Africa. A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville; 2004.
5. W.R. Taylor, and N.J. White Antimalarial drug toxicity Drug Safety 27 1 2004 25 61
6. Qinghaosu Antimalarial Coordinating Research Group Antimalarial studies on qinghaosu Chin Med J 92 1979 811 816
7. T.T. Hien, and N.J. White Qinghaosu Lancet 341 1993 603 608
8. R.N. Price Artemisinin drugs: novel antimalarial agents Expert Opin Investig Drugs 9 8 2000 1815 1827
9. M. Adjuik, A. Babiker, P. Garner, P. Olliaro, W. Taylor, N. White International Artemisinin Study Group Artesunate combinations for treatment of malaria: meta-analysis Lancet 363 9402 2004 9 17
10. World Health Organization. Antimalarial drug combination therapy. WHO 2001. WHO/CDS/RBM/2001.35.
11. World Health Organization. Assessment of the safety of artemisinin compounds in pregnancy. Report of two informal consultations convened by WHO in 2002 (RBM and TDR). WHO/CDS/MAL/2003.1094.
12. L.J. Chen, M.Y. Wang, W.K. Sun, and M.Z. Liu Embryotoxicity and teratogenicity studies on artemether in mice, rats and rabbits Acta Pharmacol Sin 5 2 2004 118 122
13. Li ZL, Yang L, Liu J, Bi Y, Li G, Dai B, Ren N. Studies on teratogenicity of sodium artesunate. Zongyao Tong Bao (Bull Chin Mater Med) 1988;13(4):42-4, 63-4.
14. R.L. Clark, T.E. White, S. A Clode, I. Gaunt, P. Winstanley, and S.A. Ward Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit Birth Defects Res B Dev Reprod Toxicol 71 6 2004 380 394
15. China Cooperative Research Group on Qinghaosu and its derivatives as antimalarials. J Traditional Chin Med 1982;2(1):31-8.
16. R. McGready, T. Cho, and J.J. Cho Artemisinin derivatives in the treatment of falciparum malaria in pregnancy Trans R Soc Trop Med Hyg 92 1998 430 433
17. R. McGready, T. Cho, and Samuel Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy Trans R Soc Trop Med Hyg 95 6 2001 651 656
18. R. McGready, A. Brockman, T. Cho, and Samuel Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy Trans R Soc Trop Med Hyg 94 6 2000 689 693
19. R. McGready, T. Cho, and N.K. Keo Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum Clin Infect Dis 33 12 2001 2009 2016
20. R. McGready, and F. Nosten The Thai-Burmese border: drug studies of Plasmodium falciparum in pregnancy Ann Trop Med Parasitol 93 Suppl. 1 1999 19 23
21. A. Brockman, R.N. Price, and M. van Vugt Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine Trans R Soc Trop Med Hyg 94 5 (September-October) 2000 537 544
22. V. Navaratnam, S.M. Mansor, N.W. Sit, J. Grace, Q. Li, and P. Olliaro Pharmacokinetics of artemisinin-type compounds Clin Pharmacokinet 39 4 2000 255 270
23. T.Q. Binh, K.F. Ilett, and K.T. Batty Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria Br J Clin Pharmacol 51 6 2001 541 546
24. P.N. Newton, M. van Vugt, and P. Teja-Isavadharm Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria Antimicrob Agents Chemother 46 4 2002 1125 1127
25. D.A.T. New Whole embryo culture and the study of mammalian embryos during organogenesis Biol Rev 53 1978 81 122
26. N.A. Brown, and S. Fabro Quantitation of rat embryonic development in vitro: a morphological scoring system Teratology 24 1981 65 78
27. L.I. Zon Developmental biology of hematopoiesis Blood 8 1995 2876 2891
28. P.L. Olliaro, R.K. Haynes, B. Meunier, and Y. Yuthavong Possible modes of action of the artemisinin-type compounds Trends Parasitol 17 3 2001 122 126
29. WHO informal consultation on clinical neurological investigations required for patients treated with artemisinin compounds and derivatives. Report of an informal consultation convened by WHO, Geneva, July 20; 1998 [TDR/TDF/99.1].
30. H.H. Chen, H.J. Zhou, G.D. Wu, and X.E. Lou Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1 Pharmacology 71 1 2004 1 9
31. S.L. Smith, J.L. Maggs, G. Edwards, S.A. Ward, B.K. Park, and W.G. McLean The role of iron in neurotoxicity: a study of novel antimalarial drugs Neurotoxicology 19 4-5 1998 557 559
32. T. Efferth, A. Benakis, and M.R. Romero Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron Free Radic Biol Med 37 7 2004 998 1009
33. H. Choe, J.M. Hansen, and C. Harris Spatial and temporal ontogenesis of glutathione peroxidase, and glutathione disulfide reductase during development of the prenatal rat J Biochem Mol Toxicol 15 4 2001 197 206
34. C. Harris, M. Dixon, and J.M. Hansen Gluthatione depletion modulates methanol, formaldehyde and formate toxicity in culture rat conceptuses Cell Biol Toxicol 20 2004 133 145
35. S. Parapini, N. Basilico, M. Mondani, P. Olliaro, D. Taramelli, and D. Monti Evidence that hem iron in the malaria parasite is not needed for the antimalarial effects of artemisinin FEBS Lett 575 1-3 2004 91 94
36. U. Eckstein-Ludwig, R.J. Webb, and I.D. van Goethem Artemisinins target the SERCA of Plasmodium falciparum Nature 424 6951 2003 957 961